ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,013Medicare Part D Prescriptions Filled, Including Refills

Rank: 471 out of 2061

$555K Total Retail Price of All Prescriptions

Rank: 573 out of 2061

387 Patients Receiving at Least One Drug in Part D
91%Patients 65 Years and Older
55% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Ohio
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

10% of this provider’s 387 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

1% of this provider’s 9,414 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

27% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$55 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

26 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Ohio
SIMVASTATIN 439 425 1 1
AMLODIPINE BESYLATE 363 350 2 4
OMEPRAZOLE 346 323 3 5
LEVOTHYROXINE SODIUM 332 311 4 3
LISINOPRIL 277 268 5 2
ATORVASTATIN CALCIUM 245 244 6 8
ZOLPIDEM TARTRATE 242 219 7 23
TRAMADOL HCL 193 179 8 18
NEXIUM 191 182 9 26
POLYETHYLENE GLYCOL 3350 190 189 10 64
CRESTOR 187 169 11 31
LOVASTATIN 185 168 12 35
LOSARTAN POTASSIUM 182 182 13 17
LISINOPRIL-HYDROCHLOROTHIAZIDE 169 160 14 27
BISOPROLOL-HYDROCHLOROTHIAZIDE 159 154 15 152
CITALOPRAM HBR 153 151 16 20
FUROSEMIDE 151 144 17 6
DIOVAN 149 143 18 41
POTASSIUM CHLORIDE 148 148 19 16
METOPROLOL TARTRATE 144 139 20 7
TAMSULOSIN HCL 130 119 21 30
METFORMIN HCL 127 111 22 9
SERTRALINE HCL 120 112 23 21
DIOVAN HCT 115 102 24 99
ATENOLOL 114 102 25 13
GABAPENTIN 111 99 26 15
ALLOPURINOL 110 103 27 28
TRIAMTERENE-HCTZ 105 105 28 38
GLIPIZIDE ER 104 87 29 133
HYDROCODONE-ACETAMINOPHEN 103 98 S3 30 10
LIDODERM 100 100 31 106
METOPROLOL SUCCINATE 99 81 32 19
DEXILANT 95 78 33 236
HYDROCHLOROTHIAZIDE 94 89 34 12
WARFARIN SODIUM 89 83 35 11
LOSARTAN-HYDROCHLOROTHIAZIDE 88 86 36 50
VOLTAREN 88 88 36 260
AZITHROMYCIN 86 75 38 34
LIPITOR 77 77 39 70
NIFEDIPINE ER 72 69 40 134
OXYBUTYNIN CHLORIDE ER 72 70 40 80
RANITIDINE HCL 68 68 42 53
ALENDRONATE SODIUM 63 63 43 25
GLIPIZIDE 62 58 44 55
CARVEDILOL 59 59 45 22
ZETIA 56 55 46 68
AMITRIPTYLINE HCL 54 50 R 47 89
JANUVIA 52 46 48 51
GLIPIZIDE XL 52 52 48 197
DILTIAZEM ER 52 52 48 248
FLUTICASONE PROPIONATE 50 50 51 43
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 22, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.